Showing results (391-400 of 466) with videos related to

Sort By:
Pageof 47
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2022
Severity of the clinical presentation of hepatitis A in five European countries from 1995 to 2014Ettore Severi, Leonidas Georgalis, Roan Pijnacker, et al.
BMC Pulmonary Medicine|December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
European Journal of Internal Medicine|August 19, 2025
Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patientsElisabetta Goni, Jens Vikse, Marco Lanzillotta, et al.
Rheumatology (Oxford, England)|June 19, 2021
Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohortMichael Hughes, Calvin Heal, Jörg Henes, et al.
European Journal of Internal Medicine|March 20, 2026
Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohortJens Vikse, Marco Lanzillotta, Elisabetta Goni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 15, 2017
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic SclerosisJérôme Avouac, Christophe Guignabert, Anna Maria Hoffmann-Vold, et al.
Rheumatology (Oxford, England)|May 14, 2021
Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR databaseMichele Iudici, Matthias Jarlborg, Kim Lauper, et al.
Rheumatology (Oxford, England)|August 14, 2025
A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC ScoreCosimo Bruni, Lorenzo Tofani, Håvard Fretheim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
Anticentromere Antibody Levels and Isotypes and the Development of Systemic SclerosisNina M van Leeuwen, Maaike Boonstra, Jaap A Bakker, et al.
Plos One|May 22, 2020
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trialHåvard Fretheim, Brian K Chung, Henriette Didriksen, et al.
Pageof 47